Replimune Group, Inc.
Replimune Group, Inc. (REPL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
repl · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$14.00
Consensus
$14.00
+57.7% upside
Low
$14.00
Median: $14 · Last Close: $8.88
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Short-term predictions are paused during the ±3-day earnings window to avoid unreliable signals.
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · REPL · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | Wedbush | Maintains | Neutral→Neutral |
| 2026-04-13 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2026-04-13 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-04-13 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
| 2026-04-13 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2026-04-13 | HC Wainwright & Co. | Downgrade ↓ | Buy→Sell |
| 2026-04-13 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-02-05 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-02-04 | Wedbush | Maintains | Outperform→Outperform |
| 2025-11-03 | BMO Capital | Upgrade ↑ | Underperform→Market Perform |
Wall Street analysts have recently issued updated ratings on Replimune Group, Inc. (REPL) stock. Of the recent 92 rating actions, 8 were upgrades and 15 were downgrades. 15 analysts currently cover REPL.
Analyst Recommendation Trends
REPL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 92.8% YoY
Revenue Next Year
$18M
↑ 963.4% YoY
EPS This Year
$-3.25
EPS Next Year
$-1.81
↓ 44.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast REPL EPS of $-3.25 for the current fiscal year, based on estimates from 5 analysts. The REPL revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The REPL stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus REPL price target is $14.00 (+57.7% upside), with an analyst consensus of Buy.
Replimune Group, Inc. trades on NASDAQ under the ticker REPL. The REPL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 47% of covering analysts.
Frequently asked questions
REPL forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month REPL price target is $14.00, with a high forecast of $14.00 and a low of $14.00. The median price target is shown in the chart above when available. This implies +57.7% potential upside from the current price of $8.88.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.